title: Disease management programs: benchmarking costs, savings, ROI.
abstract: Consumer and employer demands, financial pressures, and accreditation requirements have propelled disease management into its own fledgling industry, but there is still no one-stop shop for information, at least not for free. Experts suggest using a disease management vendor's guaranteed savings, not the fee per patient, as a benchmark. Middle- to high-priced vendors are generally the most cost-effective. Factors that affect costs include your patient mix, the amount of risk you want the vendor to assume, and how many bells and whistles you want in your program.
mesh_terms: D001249:Asthma / Q000191:economics / Q000628:therapy; D019985:Benchmarking; D002908:Chronic Disease / Q000191:economics*; D003284:Contract Services / Q000191:economics; D017046:Cost Savings; D003362:Cost-Benefit Analysis; D003659:Decision Making, Organizational; D003920:Diabetes Mellitus / Q000191:economics / Q000628:therapy; D019468:Disease Management; D017598:Efficiency, Organizational; D006333:Heart Failure / Q000191:economics / Q000628:therapy; D006801:Humans; D007449:Investments; D014481:United States